TGFβRI-IN-3

TGFβRI-IN-3

T658784-5mg

5mg

≥98%

-20°C储存

超低温冰袋运输

TGFβRI-IN-3 inhibits TGFβR1 at an IC 50 of 0.79 nM with 2000-fold selectivity against MAP4K4. TGFβRI-IN-3 represents a highly selective TGFβR1 inhibitor that has potential applications in immuno-oncology. Appearance:Solid IC50& Target:IC50: 0.79 nM (TGFβR1) In Vitro:TGFβRI-IN-3 inhibits TGFβR1 at an IC 50 of 0.79 nM with 2000-fold selectivity against MAP4K4. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Biological Activity:TGFβRI-IN-3 inhibits TGFβR1 at an IC 50 of 0.79 nM with 2000-fold selectivity against MAP4K4. TGFβRI-IN-3 represents a highly selective TGFβR1 inhibitor that has potential applications in immuno-oncology.

C28H23N3O2S

465.57 g/mol

CS(C1=CC=C(C=C1)C2=CC=C3C(NC4=CC=NC(C5=CC(C)=CC=C5)=C4)=CC=NC3=C2)(=O)=O

DMSO : 50 mg/mL (107.40 mM; ultrasonic and warming and heat to 60°C)